MedPath

Phase II study of allogeneic hematopoietic stem cell transplantation using a preparative regimens consisting of iv Bu + Flu + L-PAM for patients with juvenile myelomonocytic leukemia (JMML)

Phase 2
Recruiting
Conditions
Juvenile myelomonocytic leukemia (JMML)
Registration Number
JPRN-UMIN000005936
Lead Sponsor
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
43
Inclusion Criteria

Not provided

Exclusion Criteria

Diagnosis of Noonan syndrome, disorders with germline RAS mutations and ALPS-like diseases with somatic RAS mutations. Intracranial hemorrhage. Heart failure requiring treatment. Chronic renal failure. Active uncontrolled infections. Uncontrolled diabetes mellitus. Liver cirrhosis. Psychiatric problems.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath